Exercise Dose and All-cause Mortality Within Extended Cardiac Rehabilitation: a Cohort Study
Overview
Authors
Affiliations
Aims: To investigate the relationship between exercise participation, exercise 'dose' expressed as metabolic equivalent (MET) hours (h) per week, and prognosis in individuals attending an extended, community-based exercise rehabilitation programme.
Methods: Cohort study of 435 participants undertaking exercise-based cardiac rehabilitation (CR) in Leeds, West Yorkshire, UK between 1994 and 2006, followed up to 1 November 2013. MET intensity of supervised exercise was estimated utilising serial submaximal exercise test results and corresponding exercise prescriptions. Programme participation was routinely monitored. Cox regression analysis including time-varying and propensity score adjustment was applied to identify predictors of long-term, all-cause mortality across exercise dose and programme duration groups.
Results: There were 133 events (31%) during a median follow-up of 14 years (range, 1.2 to 18.9 years). The significant univariate association between exercise dose and all-cause mortality was attenuated following multivariable adjustment for other predictors, including duration in the programme. Longer-term adherence to supervised exercise training (>36 months) was associated with a 33% lower mortality risk (multivariate-adjusted HR: 0.67; 95% CI: 0.47 to 0.97; p=0.033) compared with all lesser durations of CR (3, 12, 36 months), even after adjustment for baseline fitness, comorbidities and survivor bias.
Conclusion: Exercise dose (MET-h per week) appears less important than long-term adherence to supervised exercise for the reduction of long-term mortality risk. Extended, supervised CR programmes within the community may play a key role in promoting long-term exercise maintenance and other secondary prevention therapies for survival benefit.
Mahmood A, Ray R, Bin Salam S, Haque F, Akkaldevi J, Masmoum M Cureus. 2024; 16(10):e72450.
PMID: 39600765 PMC: 11588675. DOI: 10.7759/cureus.72450.
Senanayake S, Halahakone U, Abell B, Kularatna S, McCreanor V, McPhail S BMC Health Serv Res. 2023; 23(1):512.
PMID: 37208666 PMC: 10198753. DOI: 10.1186/s12913-023-09546-w.
Cardiac rehabilitation performance predicts 1-year major adverse cardiovascular events.
Naami R, Naami E, Omari T, Lowi S, Natanzon S, Patel V Clin Cardiol. 2022; 45(10):1036-1043.
PMID: 35904222 PMC: 9574735. DOI: 10.1002/clc.23890.
Dose of Cardiac Rehabilitation to Reduce Mortality and Morbidity: A Population-Based Study.
Medina-Inojosa J, Grace S, Supervia M, Stokin G, Bonikowske A, Thomas R J Am Heart Assoc. 2021; 10(20):e021356.
PMID: 34612055 PMC: 8751887. DOI: 10.1161/JAHA.120.021356.
Le Grande M, Beauchamp A, Driscoll A, Jackson A BMC Cardiovasc Disord. 2020; 20(1):147.
PMID: 32209053 PMC: 7092582. DOI: 10.1186/s12872-020-01430-3.